About Us
The UCLA Health Hematologic Malignances and Cellular Therapies program is part of the UCLA Jonsson Comprehensive Cancer Center. Our cancer program includes deep clinical expertise across the board to support patients who have life-threatening disease of the blood and bone marrow. Using the most advanced therapies and transplant techniques, we can offer your best chance at recovery. For more information regarding the UCLA Health Hematologic Malignances and Cellular Therapies program please visit us at uclahealth.org/transplants/bmt. UCLA Health is ranked as one of the nation’s “Best Hospitals” in cancer by U.S. News & World Report. The UCLA Health Jonsson Comprehensive Cancer Center has been designated “comprehensive” by the National Cancer Institute since 1976. The UCLA Health Jonsson Comprehensive Cancer Center is one of 30 leading cancer centers in the United States participating in the National Comprehensive Cancer Network (NCCN). With a membership of more than 500 physicians and scientists, UCLA Health’s Jonsson Comprehensive Cancer Center is one of the largest comprehensive cancer centers in the nation. For more information regarding the UCLA Health Jonsson Comprehensive Cancer Center, please visit us at https://cancer.ucla.edu/.
LLS Campaigns
